Aminoacyl-tRNA Synthetase
Read More about this categoryShow Less
Aminoacyl-tRNA Synthetases (AARSs) are ubiquitous and evolutionarily conserved enzymes that catalyze the highly specific acylation of amino acids to cognate tRNAs. Aminoacyl-tRNA Synthetases are essential for accurate decoding of the triplet genetic code and for sustenance of all domains of life, including bacteria, archaea, and eukarya.
Aminoacyl-tRNA Synthetases also perform critical cellular activities unrelated to their primary function in aminoacylation. These noncanonical activities include regulation of gene transcription, mRNA translational control, angiogenesis, apoptosis, amino acid sensing, and cell signaling.
Products Related to Aminoacyl-tRNA Synthetase(11)
- GC32149Aminoacyl tRNA synthetase-IN-1CAS: 219931-45-0Purity: >99.50%
Aminoacyl tRNA synthetase-IN-1 is a bacterial aminoacyl tRNA synthetase (aaRS) inhibitor.
- GC32366GlyRS-IN-1CAS: 112921-11-6Purity: >98%
GlyRS-IN-1 is a glycyl-tRNA synthase (GlyRS) inhibitor extracted from patent WO 2017066459 A1.
- GC34331Gln-AMS TFAPurity: >98%
Gln-AMS TFA is an aminoacyl-tRNA synthetase (AARS) inhibitor, with the K i value of 1.32μM.
- GC65058LysRs-IN-2CAS: 2170696-76-9Purity: >99.50%
LysRs-IN-2 is a lysyl-tRNA synthetase (KRS) inhibitor with IC50s of 0.015 μM and 0.13 μM for Plasmodium falciparum lysyl-tRNA synthetase (PfKRS) and Cryptosporidium parvum lysyl-tRNA synthetase (CpKRS), respectively.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC30293 | Arg-AMS | 301351-95-1 | >98.00% | |
Arg-AMS is a potent nanomolar inhibitor of arginyl tRNA synthetase, which displays tightly bound inhibitory characteristics for the A-domains in non-ribosomal peptide synthetases (NRPS) enzymes. | ||||
| GC30683 | Gln-AMS | 209543-57-7 | >99.50% | |
Gln-AMS is an aminoacyl-tRNA synthetase (AARS) inhibitor, with the K i value of 1.32μM. | ||||
| GC31432 | Asp-AMS | 828288-98-8 | >98% | |
Asp-AMS, an analogue of aspartyl-adenylate, is an aspartyl-tRNA synthetase inhibitor and also a strong competitive inhibitor of the mitochondrial enzyme. | ||||
| GC32121 | Leu-AMS | 288591-93-5 | >99.00% | |
Leu-AMS (compound 6), a leucine analogue, is a potent inhibitor of leucyl-tRNA synthetase (LRS) with an IC50 of 22.34 nM, which inhibits the catalytic activity of LRS but did not affect the leucine-induced mTORC1 activation. | ||||
| GC32149 | Aminoacyl tRNA synthetase-IN-1 | 219931-45-0 | >99.50% | |
Aminoacyl tRNA synthetase-IN-1 is a bacterial aminoacyl tRNA synthetase (aaRS) inhibitor. | ||||
| GC32366 | GlyRS-IN-1 | 112921-11-6 | >98% | |
GlyRS-IN-1 is a glycyl-tRNA synthase (GlyRS) inhibitor extracted from patent WO 2017066459 A1. | ||||
| GC34331 | Gln-AMS TFA | - | >98% | |
Gln-AMS TFA is an aminoacyl-tRNA synthetase (AARS) inhibitor, with the K i value of 1.32μM. | ||||
| GC34358 | Leu-AMS R enantiomer | - | >98% | |
Leu-AMS R enantiomer is the R enatiomer of Leu-AMS. | ||||
| GC65058 | LysRs-IN-2 | 2170696-76-9 | >99.50% | |
LysRs-IN-2 is a lysyl-tRNA synthetase (KRS) inhibitor with IC50s of 0.015 μM and 0.13 μM for Plasmodium falciparum lysyl-tRNA synthetase (PfKRS) and Cryptosporidium parvum lysyl-tRNA synthetase (CpKRS), respectively. | ||||
| GC79562 | BC-DXI-495 | 2421117-94-2 | >99.00% | |
BC-DXI-495 is a AIMP2-DX2 inhibitor. | ||||
| GC81879 | NCP26 TFA | - | >99.50% | |
NCP26 TFA is an ATP-competitive ProRS inhibitor (with a K D of 271 nM in the absence of proline, and a K D of 0.35 nM in the presence of 100 μM proline). | ||||
